A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Pirtobrutinib and venetoclax combination overcomes resistance to targeted and CAR Tcell therapy in aggressive mantle cell lymphoma
2022
Haematologica
Not available.
doi:10.3324/haematol.2022.282031
fatcat:uarjrrf3xvhjnfax6qxrfvatre